May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
IL-33 Contributes to Host Resistance Against Pseudomonas Aeruginosa Keratitis by Promoting a Th2 Immune Response
Author Affiliations & Notes
  • X. Huang
    Anatomy & Cell Biology, Wayne State Univ Sch of Med, Detroit, Michigan
  • W. Du
    Anatomy & Cell Biology, Wayne State Univ Sch of Med, Detroit, Michigan
  • S. A. McClellan
    Anatomy & Cell Biology, Wayne State Univ Sch of Med, Detroit, Michigan
  • L. D. Hazlett
    Anatomy & Cell Biology, Wayne State Univ Sch of Med, Detroit, Michigan
  • Footnotes
    Commercial Relationships  X. Huang, None; W. Du, None; S.A. McClellan, None; L.D. Hazlett, None.
  • Footnotes
    Support  R01 EY016058 and P30 EY04068
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2823. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X. Huang, W. Du, S. A. McClellan, L. D. Hazlett; IL-33 Contributes to Host Resistance Against Pseudomonas Aeruginosa Keratitis by Promoting a Th2 Immune Response. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2823. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To elucidate the role of IL-33, a specific ligand of the IL-1/TLR receptor family member ST2, in resistance to Pseudomonas aeruginosa (P. aeruginosa) keratitis.

Methods: : IL-33 mRNA expression was tested using real-time RT-PCR in C57BL/6 (B6) vs. BALB/c mice before and after P. aeruginosa (1x106 CFU/µl, ATCC strain 19660) challenge. Infected B6 mice also were tested after subconjunctival injection with recombinant mouse IL-33 (rmIL-33) protein or PBS. Corneal disease progress was monitored by clinical score and cytokines/chemokines were tested by real-time PCR and ELISA assays. To further investigate IL-33 regulation of corneal inflammation, an in vitro study was performed using RAW264.7 macrophage-like cells in which ST2 was overexpressed and stimulation of these cells with recombinant mouse IL-33. Cytokine/chemokine expression in rmIL-33 vs. PBS treated cells was measured by real-time PCR and/or ELISA.

Results: : IL-33 mRNA was constitutively expressed in the uninfected, normal cornea of both mouse groups. IL-33 mRNA levels in the cornea of BALB/c vs. B6 mice were elevated significantly at 1-5 days p.i., and peaked at 3 days p.i. B6 mice treated with rmIL-33 compared with PBS controls showed decreased corneal opacity and less perforation (at 5 days p.i.). These mice also exhibited lower corneal mRNA levels for IL-1β, MIP-2 and TNF-α. In contrast, production of an anti-inflammatory cytokine (TGF-β) and Th2-type cytokines (IL-4, -5 and -10) were significantly upregulated. Protein levels for TNF-α and IL-10 were selectively confirmed by ELISA in the cornea of rmIL-33 vs. PBS treated mice. In vitro, RAW264.7 cells transiently transfected with ST2 and stimulated with rmIL-33 vs. PBS also showed significantly increased Th2-type cytokines, but markedly decreased Th1-type cytokine (IFN-γ) as well as IL-1β and MIP-2 production.

Conclusions: : IL-33 participates in resistance to P. aeruginosa keratitis by negatively regulating corneal inflammation through promotion of a Th2-type immune response and up-regulation of anti-inflammatory cytokine (TGF-β) production.

Keywords: inflammation • keratitis • pseudomonas 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×